The usefulness of bevacizumab for relief from symptomatic malignant ascites in patients with heavily treated recurrent ovarian cancer
about
The usefulness of bevacizumab for relief from symptomatic malignant ascites in patients with heavily treated recurrent ovarian cancer
description
scientific article published on 29 August 2019
@en
name
The usefulness of bevacizumab ...... eated recurrent ovarian cancer
@en
type
label
The usefulness of bevacizumab ...... eated recurrent ovarian cancer
@en
prefLabel
The usefulness of bevacizumab ...... eated recurrent ovarian cancer
@en
P50
P356
P1476
The usefulness of bevacizumab ...... eated recurrent ovarian cancer
@en
P2093
Toru Nakanishi
Yusuke Shimizu
P304
P356
10.1111/JOG.14112
P577
2019-08-29T00:00:00Z